IQI
IRWD icon

Integrated Quantitative Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

Integrated Quantitative Investments’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.94M Buy
552,104
+449,450
+438% +$1.84M 0.35% 77
2025
Q4 		$346K Buy
+102,654
New +$267K 0.07% 308

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Integrated Quantitative Investments's IRWD Position: Q1 2026 in Review

Integrated Quantitative Investments increased its Ironwood Pharmaceuticals (IRWD) stake by 438% in Q1 2026, buying an estimated $1.84M and bringing the position to 552,104 shares worth $1.94M. The position accounts for 0.35% of the portfolio, ranked #77.

Integrated Quantitative Investments first reported a position in IRWD in Q4 2025 and has held it in 2 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Integrated Quantitative Investments held 552,104 shares of Ironwood Pharmaceuticals worth $1.94M as of Q1 2026.
  • Integrated Quantitative Investments bought 449,450 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $1.84M.
  • Ironwood Pharmaceuticals made up 0.35% of Integrated Quantitative Investments's portfolio in Q1 2026, its #77 holding.
  • Integrated Quantitative Investments first reported a position in Ironwood Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Integrated Quantitative Investments's 13F filing for Q1 2026, filed 13 May 2026.